Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Drug Withdrawal Symptoms

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Drug Withdrawal Symptoms in 2 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Research Excerpts

ExcerptRelevanceReference
" Aspirin was injected at 100 mg/kg, 1 mg/kg and at several different aspirin dilutions along with cyclooxygenase (COX) 1 (SC-560), COX 2 (NS-398) or both selective inhibitors simultaneously using a laser-induced thrombosis model."3.76Paradoxical thrombotic effects of aspirin: experimental study on 1000 animals. ( Aguejouf, O; Desplat, V; Doutremepuich, C; Eizayaga, FX, 2010)
"We studied the effects of ultra-low-dose aspirin (ULDA) as well as those of sc-560 and ns-398, specific COX-1 and COX-2 inhibitors, on induced hemorrhagic time and in a model of laser-induced thrombosis in rats."3.74Reverse effect of aspirin: is the prothrombotic effect after aspirin discontinuation mediated by cyclooxygenase 2 inhibition? ( Aguejouf, O; Desplat, V; Doutremepuich, C; Eizayaga, FX, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doutremepuich, C2
Aguejouf, O2
Desplat, V2
Eizayaga, FX2

Other Studies

2 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Drug Withdrawal Symptoms

ArticleYear
Paradoxical thrombotic effects of aspirin: experimental study on 1000 animals.
    Cardiovascular & hematological disorders drug targets, 2010, Volume: 10, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Dose-Response

2010
Reverse effect of aspirin: is the prothrombotic effect after aspirin discontinuation mediated by cyclooxygenase 2 inhibition?
    Pathophysiology of haemostasis and thrombosis, 2007, Volume: 36, Issue:1

    Topics: Animals; Aspirin; Bleeding Time; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cy

2007